Nippon India Nifty Pharma ETF
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Nifty Pharma ETF
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Exchange Traded Funds (ETFs)
Launch Date
: 21-Jun-2021
Fund Manager
: Jitendra Tolani
Net Assets (Rs. cr)
: 1570.17
Nippon India Nifty Pharma ETF - Nav Details
Nav Date
: 02-Jul-2026
NAV [Rs.]
: 25.9779
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: Nil
Nippon India Nifty Pharma ETF- NAV Chart
Nippon India Nifty Pharma ETF- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 1.35 | 5.48 | 16.1 | 11.29 | 15 | 23.03 | - | 12.53 |
| Category Avg | 0.78 | 1.43 | 10.2 | -2.61 | 8.56 | 16 | 11.96 | 12.63 |
| Category Best | 5.49 | 12.68 | 32.93 | 41.57 | 112.19 | 47.88 | 30 | 137.88 |
| Category Worst | -1.35 | -14.05 | -10.96 | -90.2 | -78.96 | -1.2 | 0.34 | -22.02 |
Nippon India Nifty Pharma ETF- Latest Dividends
No Records Found
Nippon India Nifty Pharma ETF- Investment Details
Min. Investment(Rs.)
: 1000
Increm.Investment(Rs.)
: 0
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 21.42 | 1869418 | 336.34 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 9.53 | 224373 | 149.58 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 8.93 | 1075921 | 140.24 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 8.86 | 993316 | 139.16 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 6.18 | 428234 | 97.11 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 5.96 | 686956 | 93.56 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 5.19 | 184671 | 81.45 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 4.48 | 493546 | 70.39 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 3.85 | 265843 | 60.47 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 3.62 | 103310 | 56.79 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 3.44 | 1260096 | 54.01 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 3.03 | 441677 | 47.59 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 3.02 | 199769 | 47.45 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.38 | 245210 | 37.37 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.01 | 140517 | 31.61 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 2.00 | 144528 | 31.32 |
| Equity | Wockhardt | Pharmaceuticals & Biotechnology | 1.89 | 145846 | 29.62 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 1.57 | 9194 | 24.69 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 1.39 | 74378 | 21.78 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 1.20 | 1094059 | 18.90 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
7,40,030.99
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Jitendra Tolani
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
